Loading clinical trials...
Loading clinical trials...
Browse 4,613 clinical trials for ulcerative colitis. Find studies that match your criteria and connect with research centers.
Find trials near:
Showing 1321-1340 of 4,613 trials
NCT06351878
A validation study has been designed to assess the performance of a home sleep test device, TipTraQ, for screening sleep apnea. The study involves participants wearing the TipTraQ device on their fingertip during a traditional sleep test, known as polysomnography (PSG), conducted in a sleep center. The performance of the device will then be evaluated by comparing the results from the TipTraQ system with those from the traditional sleep test.
NCT06650657
This research aims to evaluate the effect of Touchpoint experience as a clinical learning method on clinical learning. The research is a quasi-experimental research with experimental-control groups. Students will be divided into experimental and control groups with the "simple randomization" method. A pre-test will be taken with data collection tools before the study for both groups. Students in the control group will continue their routine practice experiences. A post-test will be applied with data collection tools at the end of the 8-week internship period. TouchPoint is planned as a 2-session experience over a semester: Session 1 focuses on patient-centered care, Session 2 focuses on teamwork and collaboration. The method of both sessions will be conducted by 2 researchers with a small clinical group of 8 to 10 students. Sessions will last from 1.5 hours to 2 hours depending on the number of students and the degree of discussion. Sessions will be conducted face-to-face in a classroom.
NCT01938261
Present randomized, controlled, double-blind trial investigates the efficacy and safety of early (\<24 h) intravenous paracetamol therapy for pain medication in very small premature infants. This phase 2 drug study focuses on the efficacy and safety of short-term use. The pharmacokinetics and pharmacodynamics of paracetamol, as well as the long-term effects, are studied. This study recruits preterm infants born less than 32 weeks gestational age and treated at the neonatal intensive care unit of Oulu University Hospital. The informed consent is asked from all parents. The first drug dose is given before 24 hours of age. Masked study drug is paracetamol infusion solution 10 mg/mL or placebo, 0.45% saline solution. The loading dose is 20 mg/kg, and the maintenance dose 7.5 mg/kg every 6 hours for 4 days. The exact date of the closure of ductus is studied by repeated echocardiographic examinations. The symptoms of pain are screened by a pain scale of preterm infants (NIAPAS). Patients are monitored for signs of possible side effects. After discharge from hospital, patients are examined at follow-up clinic for the first year every 3 months and at 2 years of age.